Skip to main content
RGEN logo

Repligen Corporation

RGENNASDAQHealthcareMedical Instruments & Supplies

$178.71Today:- (-)1Y +8.18%

As of Oct 22, 2026 close

Market cap
$10.13B
P/E (TTM)
243.77
Forward P/E
-
Dividend yield
-
52-week range
$100.99$198.87
Volume (live)
-
Avg. volume (3M)
1.22M

Repligen (RGEN) Income Statement

Repligen reported revenue of $738.26M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 16.4% from $634.44M a year earlier. Net income was $48.89M, a net margin of 6.6%. Gross margin was 52.3% and operating margin 5.6%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $204.13M, up 11.9% from the same quarter a year earlier.

Repligen Income Statement Analysis

Values in millions USD

Scroll to see more
Repligen Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue738.26634.44632.36801.54670.53366.26270.25194.03141.24
Cost of Revenue352.01315.77323.54345.83279.28155.90132.0285.9567.05
Gross Profit386.25274.65278.44455.71391.25210.36138.23108.0874.19
Operating Expenses
Research & Development54.1842.7542.6143.9434.2720.1819.4515.778.67
Selling, General & Administrative290.51238.28216.89215.83183.87115.6278.6966.3251.51
Operating Expenses344.69309.76230.74231.04224.01135.8098.1482.0960.18
Operating Income41.56-35.1147.70224.67167.2574.5640.0825.9914.01
Other Income/Expense
Interest Income27.5735.8324.146.980.181.740.000.000.00
Interest Expense21.51-22.57-10.58-2.98-12.71-12.139.296.716.44
Other Income/Expense44.0016.1618.01-11.06-27.41-0.21-13.93-4.55-6.76
Income
Income Before Tax62.38-27.0456.71219.14153.5459.2226.1521.447.25
Income Tax Expense13.49-1.5221.1133.1825.25-0.714.744.82-21.11
Net Income48.89-25.5135.60185.96128.2959.9321.4116.6228.35
Net Income - Continuous Operations48.89-25.5135.60185.96128.2959.9321.4116.6228.35
Net Income - Discontinued Operations---------
EBITDA180.85107.30114.07246.93211.56101.6256.3141.7724.14
EBIT83.9037.6549.33195.94173.1174.56---
Depreciation & Amortization96.9669.6564.7450.9938.4527.0720.8715.7810.45
Earnings Per Share
Basic EPS1.00-1.003.002.001.00--1.00
Diluted EPS1.00-1.003.002.001.00--1.00
Basic Shares Outstanding56.2355.9455.7255.4655.0252.5548.3443.7738.23
Diluted Shares Outstanding56.5655.9456.3857.4657.2653.8949.2145.4739.15

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Repligen Financial Statements

What was Repligen's revenue in fiscal 2025?

Repligen reported revenue of $738.26M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 16.4% from $634.44M a year earlier.

Is Repligen profitable?

Yes. Repligen earned net income of $48.89M in fiscal 2025, a net margin of 6.6%. In fiscal 2024 it lost $25.51M.

What is Repligen's operating margin?

Repligen's operating income was $41.56M on revenue of $738.26M in fiscal 2025, an operating margin of 5.6%, compared with -5.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition